NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001380

Registered date:17/09/2008

Prognostic Value of Cardiac Sympathetic Nerve Activity Evaluated by 123I-Metaiodobenzylguanidine Imaging in Patients with ST-Segment Elevation Myocardial Infarction

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedST-segment elevation myocardial infarction
Date of first enrollment2000/12/01
Target sample size200
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeMajor adverse cardiac events
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1) Hepatic failure 2) Svere renal failure 3) Active cancer 4) Severe heart failure requiring mechanical support (mechanical ventilation, intraaortic balloon pumping, left ventricular assist device, or cardiac resynchronization therapy) 5) Requiring heart transplantation

Related Information

Contact

public contact
Name Shu Kasama
Address 740 Shimohakoda, Hokkitsu-machi, Shibukawa, Gunma, Japan Japan
Telephone 027(232)7111
E-mail s-kasama@bay.wind.ne.jp
Affiliation Kitakanto Cardiovascular Hospital Internal Medicine
scientific contact
Name Shuichi Ichikawa
Address 740 Shimohakoda, Hokkitsu-machi, Shibukawa, Gunma, Japan Japan
Telephone 0272-32-7111
E-mail
Affiliation Kitakanto Cardiovascular Hospital Internal Medicine